Leung, a partner at investment firm Qiming Development (HK) who leads its healthcare investments, will depart “due to other work commitments,” the statement said.
“If we get this one right on cancer, it’s going to add this whole new positive dynamic to the overall framework of the U.S.-China relationship, the Asia Society CEO told an online symposium.
Raffles Medical Group from Singapore plans to increase the number of cities it serves in China from the current eight to 20 in the next three to five years.